Camilla joined Brann in 2013. Before Brann, Camilla worked at another IP law firm for ten years, and before that, at Karolinska Innovations AB, for three years. Camilla’s main duties at Brann include providing strategic IP advice focusing on mid-sized innovative research companies, filing and prosecuting global patent portfolios, performing due diligence and freedom-to-operate analyses, filing and prosecuting applications for supplementary protection certificates (SPC), and providing general IP advice. Having worked with clients ranging from individual inventors to mid-sized and large companies for many years, Camilla has acquired a broad expertise in advising on IP matters. Camilla’s main areas of expertise are pharmaceutical compositions, vaccine products, microbiology, genetic engineering, molecular biology, microbiology, biochemistry and immunology.